FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2939906752> ?p ?o ?g. }

• W2939906752 endingPage "4566" @default.
• W2939906752 startingPage "4552" @default.
• W2939906752 abstract "Abstract Purpose: Ewing sarcoma is an aggressive solid tumor malignancy of childhood. Although current treatment regimens cure approximately 70% of patients with localized disease, they are ineffective for most patients with metastases or relapse. New treatment combinations are necessary for these patients. Experimental Design: Ewing sarcoma cells are dependent on focal adhesion kinase (FAK) for growth. To identify candidate treatment combinations for Ewing sarcoma, we performed a small-molecule library screen to identify compounds synergistic with FAK inhibitors in impairing Ewing cell growth. The activity of a top-scoring class of compounds was then validated across multiple Ewing cell lines in vitro and in multiple xenograft models of Ewing sarcoma. Results: Numerous Aurora kinase inhibitors scored as synergistic with FAK inhibition in this screen. We found that Aurora kinase B inhibitors were synergistic across a larger range of concentrations than Aurora kinase A inhibitors when combined with FAK inhibitors in multiple Ewing cell lines. The combination of AZD-1152, an Aurora kinase B–selective inhibitor, and PF-562271 or VS-4718, FAK-selective inhibitors, induced apoptosis in Ewing sarcoma cells at concentrations that had minimal effects on survival when cells were treated with either drug alone. We also found that the combination significantly impaired tumor progression in multiple xenograft models of Ewing sarcoma. Conclusions: FAK and Aurora kinase B inhibitors synergistically impair Ewing sarcoma cell viability and significantly inhibit tumor progression. This study provides preclinical support for the consideration of a clinical trial testing the safety and efficacy of this combination for patients with Ewing sarcoma." @default.
• W2939906752 created "2019-04-25" @default.
• W2939906752 creator A5003590811 @default.
• W2939906752 creator A5005884580 @default.
• W2939906752 creator A5009997118 @default.
• W2939906752 creator A5011985711 @default.
• W2939906752 creator A5018335496 @default.
• W2939906752 creator A5022924056 @default.
• W2939906752 creator A5025643066 @default.
• W2939906752 creator A5037413866 @default.
• W2939906752 creator A5037733913 @default.
• W2939906752 creator A5044027975 @default.
• W2939906752 creator A5045161756 @default.
• W2939906752 creator A5047911953 @default.
• W2939906752 creator A5048587779 @default.
• W2939906752 creator A5053645352 @default.
• W2939906752 creator A5056881284 @default.
• W2939906752 creator A5059247439 @default.
• W2939906752 creator A5061186958 @default.
• W2939906752 creator A5068008095 @default.
• W2939906752 creator A5069062997 @default.
• W2939906752 creator A5073184572 @default.
• W2939906752 creator A5081154325 @default.
• W2939906752 creator A5091773218 @default.
• W2939906752 date "2019-07-15" @default.
• W2939906752 modified "2023-10-16" @default.
• W2939906752 title "High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma" @default.
• W2939906752 cites W1908559600 @default.
• W2939906752 cites W1918281504 @default.
• W2939906752 cites W1965440903 @default.
• W2939906752 cites W1975078069 @default.
• W2939906752 cites W1975588317 @default.
• W2939906752 cites W1982959429 @default.
• W2939906752 cites W1985164472 @default.
• W2939906752 cites W1994568630 @default.
• W2939906752 cites W1999390452 @default.
• W2939906752 cites W2000646653 @default.
• W2939906752 cites W2002736769 @default.
• W2939906752 cites W2008862544 @default.
• W2939906752 cites W2009720434 @default.
• W2939906752 cites W2013883015 @default.
• W2939906752 cites W2031211461 @default.
• W2939906752 cites W2033628442 @default.
• W2939906752 cites W2034071028 @default.
• W2939906752 cites W2043398720 @default.
• W2939906752 cites W2044423100 @default.
• W2939906752 cites W2060157525 @default.
• W2939906752 cites W2064575766 @default.
• W2939906752 cites W2065088072 @default.
• W2939906752 cites W2065215145 @default.
• W2939906752 cites W2069351898 @default.
• W2939906752 cites W2072015866 @default.
• W2939906752 cites W2072315137 @default.
• W2939906752 cites W2079012552 @default.
• W2939906752 cites W2112146471 @default.
• W2939906752 cites W2122763483 @default.
• W2939906752 cites W2124328974 @default.
• W2939906752 cites W2126572395 @default.
• W2939906752 cites W2126983941 @default.
• W2939906752 cites W2128628566 @default.
• W2939906752 cites W2146157298 @default.
• W2939906752 cites W2151962695 @default.
• W2939906752 cites W2153850465 @default.
• W2939906752 cites W2155466614 @default.
• W2939906752 cites W2157828807 @default.
• W2939906752 cites W2158485828 @default.
• W2939906752 cites W2158804011 @default.
• W2939906752 cites W2164937682 @default.
• W2939906752 cites W2166084034 @default.
• W2939906752 cites W2167452086 @default.
• W2939906752 cites W2168143310 @default.
• W2939906752 cites W2171285924 @default.
• W2939906752 cites W2222507697 @default.
• W2939906752 cites W2274409794 @default.
• W2939906752 cites W2285408387 @default.
• W2939906752 cites W2461427403 @default.
• W2939906752 cites W2900164991 @default.
• W2939906752 doi "https://doi.org/10.1158/1078-0432.ccr-17-0375" @default.
• W2939906752 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6634997" @default.
• W2939906752 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30979745" @default.
• W2939906752 hasPublicationYear "2019" @default.
• W2939906752 type Work @default.
• W2939906752 sameAs 2939906752 @default.
• W2939906752 citedByCount "29" @default.
• W2939906752 countsByYear W29399067522019 @default.
• W2939906752 countsByYear W29399067522020 @default.
• W2939906752 countsByYear W29399067522021 @default.
• W2939906752 countsByYear W29399067522022 @default.
• W2939906752 countsByYear W29399067522023 @default.
• W2939906752 crossrefType "journal-article" @default.
• W2939906752 hasAuthorship W2939906752A5003590811 @default.
• W2939906752 hasAuthorship W2939906752A5005884580 @default.
• W2939906752 hasAuthorship W2939906752A5009997118 @default.
• W2939906752 hasAuthorship W2939906752A5011985711 @default.
• W2939906752 hasAuthorship W2939906752A5018335496 @default.
• W2939906752 hasAuthorship W2939906752A5022924056 @default.
• W2939906752 hasAuthorship W2939906752A5025643066 @default.
• W2939906752 hasAuthorship W2939906752A5037413866 @default.

• next